To study the role and function of SLC39A4 in NSCLC pathogenesis, we first assessed the levels of SLC39A4 expression in normal and lung carcinoma tissues in a meta-analysis of eight GEO datasets containing clinicopathological information (Supplementary Table S1). This evidence concerns the gene SLC39A4 and lung carcinoma.